Genome-wide ER binding data collected in breast cancer cells growing in hormone-depleted media have underlined specific ligand-independent mechanisms to affect gene transcription, microRNA expression, and downstream proteome [51]. The gene discussed is ESR1; the disease is breast carcinoma.